Login
Nature Biotechnology 25, 4 - 5 (2007)doi:10.1038/nbt0107-4
Mark Hollmer1
Acquiring Tanox and its asthma franchise gives Genentech an inroad into a new therapeutic area.
ADVERTISEMENT
Top